Comprehensive range of oral and topical pharmaceuticals from licensed manufacturer partners. Quality tested tablets, capsules, syrups, drops, and ointments for clinical distribution.

High-purity pharmaceutical formulation Activeworld Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Alcipro-500 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Pharmaceutical liquid formulation Ancool SF Suspension formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
Topical pharmaceutical preparation Ashwagandha Churna engineered for targeted cutaneous application, rapid absorption, and sustained therapeutic relief. Suitable for clinical and outpatient medical prescription.
High-purity pharmaceutical formulation Atorva 20 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Pharmaceutical liquid formulation Bevon Drops 15ml formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
Pharmaceutical liquid formulation Bevon Syrup 200ml formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
High-purity pharmaceutical formulation Bio D3 Strong Capsule packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Calpol 500 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.

High-purity pharmaceutical formulation Calpol 650 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Choice Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Clavam 625mg Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Clonafit 0.25 MD Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Clonofit 0.50 MD Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Pharmaceutical liquid formulation Cofpyl-D Syrup formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
Pharmaceutical liquid formulation Cofpyl-LS Syrup formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
High-purity pharmaceutical formulation Crina NCR 10mg Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation D3 Must 60K Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Topical pharmaceutical preparation Duolin Respules engineered for targeted cutaneous application, rapid absorption, and sustained therapeutic relief. Suitable for clinical and outpatient medical prescription.
High-purity pharmaceutical formulation Dydrowell Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Pharmaceutical liquid formulation Emigo Syrup formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
High-purity pharmaceutical formulation Eryscreen Capsule packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Estro Plus Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Etoshine 90 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation F3-XT Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Feronia XT Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Pharmaceutical liquid formulation Ferozof-XT Syrup formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
High-purity pharmaceutical formulation Ferozof-XT Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Folate 9 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Folcy-XT Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Furocan 500 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Gabaneuron NT 300 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Glimy M2 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Gluconorm G1 Forte Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Pharmaceutical liquid formulation Gudlax Plus Syrup formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
High-purity pharmaceutical formulation Kanchnar Guggulu Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Lipaglyn 4mg Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation LNZ 600 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Topical pharmaceutical preparation Lrzin Sachet engineered for targeted cutaneous application, rapid absorption, and sustained therapeutic relief. Suitable for clinical and outpatient medical prescription.
Topical pharmaceutical preparation Luzcare Cream engineered for targeted cutaneous application, rapid absorption, and sustained therapeutic relief. Suitable for clinical and outpatient medical prescription.
Pharmaceutical liquid formulation Lycoviz A-Z Syrup formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
Pharmaceutical liquid formulation Lycoviz-Gold Syrup formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
Topical pharmaceutical preparation Macprot Vanilla (Protein Powder) engineered for targeted cutaneous application, rapid absorption, and sustained therapeutic relief. Suitable for clinical and outpatient medical prescription.
High-purity pharmaceutical formulation Magnisure Forte Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Magnisure LC Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Mecolyb-Gold Capsule packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Melital Q10 Capsule packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Melital-G9P Capsule packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Pharmaceutical liquid formulation Menohelp Syrup formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
High-purity pharmaceutical formulation Monticope Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Moxril CV 625 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Myotop 450 SR Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Myotop P Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Topical pharmaceutical preparation Namcold Nasal Spray engineered for targeted cutaneous application, rapid absorption, and sustained therapeutic relief. Suitable for clinical and outpatient medical prescription.
High-purity pharmaceutical formulation Naprosyn 500 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Neurogyn-LC Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Nucoxia-60 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Nupore 2.5 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation O2 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Octamax-Forte Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Pharmaceutical liquid formulation Ondem Syrup formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
High-purity pharmaceutical formulation Ostyone 500 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Ostyone D3 Capsule packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Ovalink Plus Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Ovalink SR Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Ovamir Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Topical pharmaceutical preparation Pantop HP Kit engineered for targeted cutaneous application, rapid absorption, and sustained therapeutic relief. Suitable for clinical and outpatient medical prescription.
High-purity pharmaceutical formulation Pentovic DSR Capsule packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Rablet-D Capsule packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Rabmel DSR Capsule packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Pharmaceutical liquid formulation Retamel Syrup formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
High-purity pharmaceutical formulation Richar CR 10 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Richar CR 100mg Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Rifameg 550 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Sacuval 50 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation SGLTD Trio 500 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Signoflam Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Spasmodart 10 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Sumo Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Pharmaceutical liquid formulation Sumo-L Suspension formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
High-purity pharmaceutical formulation Taxim O 200 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Taxim O DT 100 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Tendofirm Capsule packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Tentex Forte Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Tentex Royal Capsule packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Udmark 300 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Ultranise Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Unwanted 21 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Unwanted-72 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Uridis Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Urispas 15 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
Pharmaceutical liquid formulation Vitanova D3 Drops formulated for pleasant patient compliance, uniform active ingredient distribution, and rapid therapeutic onset. Supplied in tamper-evident sealed bottles.
Topical pharmaceutical preparation Volini Spray engineered for targeted cutaneous application, rapid absorption, and sustained therapeutic relief. Suitable for clinical and outpatient medical prescription.
High-purity pharmaceutical formulation Womancall Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Zerodol P Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Zerodol SP Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.
High-purity pharmaceutical formulation Zerodol TH8 Tablet packaged in protective blister foils for optimal stability. Formulated for precise therapeutic dosage, fast bioavailability, and reliable patient efficacy.